C12Y 106/02004
Nadph-hemoprotein reductase , i.e. nadp-cytochrome p450-reductase
Official title: NADPH-hemoprotein reductase (1.6.2.4), i.e. NADP-cytochrome P450-reductase
C12Y106/02004 (Nadph-hemoprotein reductase , i.e. nadp-cytochrome p450-reductase) appears on 99 US grants and 162 published applications in this corpus.
Search patents in C12Y- Granted patents
- 99
- Published applications
- 162
- Assignees
- 79
- Inventors
- 339
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 3 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 3 | 8 |
| 2016 | 5 | 9 |
| 2017 | 5 | 13 |
| 2018 | 9 | 11 |
| 2019 | 7 | 13 |
| 2020 | 6 | 12 |
| 2021 | 11 | 12 |
| 2022 | 8 | 21 |
| 2023 | 7 | 10 |
| 2024 | 7 | 16 |
| 2025 | 16 | 16 |
| 2026 | 5 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Recombinant host cells with improved production of tetraketide derivatives22 Sep 2026US 12,742,189 B2Iptector Assets Aps
- Processes for the production of tryptamines7 Apr 2026US 12,595,497 B2Compass Pathfinder Limited
- Enabling cholesterol catabolism in mammalian cells lacking same10 Feb 2026US 12,545,918 B2University of South Alabama Foundation for Research and Commercialization
- ABC transporters for the high efficiency production of rebaudiosides20 Jan 2026US 12,529,087 B2Amyris, Inc.
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Recombinant polypeptides for biosynthesis of thymohydroquinone (thq)10 Sep 2026US 2026/0265705 A1Epimeron USA, Inc.
- Abc transporters for the high efficiency production of rebaudiosides3 Sep 2026US 2026/0258467 A1Amyris, Inc.
- Recombinant host cells with improved production of tetraketide derivatives27 Aug 2026US 2026/0250728 A1Iptector Assets Aps
- Test system comprising stably cyp-transfected or transduced mammalian cells6 Aug 2026US 2026/0226427 A1Brandenburgische Technische Universität Cottbus-Senftenberg
Most cited
By later US patents
- Production of steviol glycosides in microorganisms48US 9,562,251 B2Evolva SA · 2017
- Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy34US 6,207,648 B1Trustees of Boston University · 2001
- Microbial production of natural sweeteners, diterpenoid steviol glycosides26US 9,284,570 B2Massachusetts Institute of Technology · 2016
- Efficient production of steviol glycosides in recombinant hosts19US 10,017,804 B2Evolva SA · 2018
- Processes for the production of tryptamines10US 11,136,293 B2New Atlas Biotechnologies LLC · 2021